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ABSTRACT
EARLY NURSING INTERVENTIONS AND THEIR EFFECT ON
FATIGUE IN PATIENTS RECEIVING CHEMOTHERPY
By
Karla Baker RN

Fatigue is the number one side effect Aat patients experience wiien
they receive chemotherapy. They do not always expect it or know what to do
when it effects their entire life. This stu<fy described the affect o f early nursing
interventions on Atigue caused by chemotherapy. This descriptive, two group
comparative stucfy used a convenience sample o f patients, receiving
chemotherapy for the first time, to determine the degree o f fotigue they
experienced. A tool by Barbara Piper RN (1997) was used to describe the effect
of early intervention on fatigue experienced by cancer patients undergoing
chemotherapy. Internal consistency o f this tool was previously determined to be
.97 per Cronbach’s alpha. The fatigue experience of patients was ranked fiom 0
to 10. A paired t test, independent test, and Person’s r were performed, suggesting
no significant difference between the two groups in their perception o f
chemotherapy-induced fatigue was apparent when a fatigue intervention was
introduced to one set o f patients.
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CHAPTER 1
INTRODUCTION

Patients diagnosed with cancer and undergoing chemotherapy commonly
experience fatigue, a complex and disturbing side effect that has a disquieting impact on
their quality of life. Many cancer patients expect side effects from chemotherapy, but the
severity of the accompanying fatigue is seldom anticipated. Cancer patients are
physically, emotionally, and psychologically affected by fatigue and may "prematurely
withdraw from potentially curative treatment as a result o f chemotherapy side effects"
(Winningham, Nail, Burke, Brophy, Cimprich, & Jones, 1994).
Approximately 80% to 96% of all cancer patients experience chemotherapy
induced &tigue to a degree that disrupts their ability to perform day to day activities
(Irvine, Vincent, Graydon, Bubela, & Thompson, 1994). Patients receiving chemotherapy
complain that health care providers do not fully understand their experience (Rhodes,
Watson, & Hanson, 1989). Although patients receiving chemotherapy expect fatigue
following chemotherapy, health care professionals may not fully explain actions that may
help to minimize the impact of fatigue on the ability of patients to perform their daily

activities. There are many approaches that oncology nurses can use in the management o f
fatigue, including patient education.
Fatigue may be described by patients as tiredness, weakness, and lack o f energy,
' lethargy, or an inability to concentrate. Fatigue, like pain, is a subjective phenomenon.
Many cancer-oriented fatigue theories support how fatigue is perceived by different
individuals (Winningham et al., 1994).
Nursing is defined as the "diagnosis and treatment o f human response to actual
or potential health problems" (American Nurse Association [ANA], 1980). Within the
discipline o f nursing, nurses are often a primary health care resource for oncology
patients experiencing fatigue. Nurses, educated in the field o f oncology, collaborate with
cancer patients to help them manage chemotherapy-induced fatigue. (Potempa, 1989).
Purpose
The purpose o f this study was to investigate early nursing interventions that
effectively minimize the nnpact o f fatigue for the chemotherapy patient. Patient
education is paramount in the control of chemotherapy-induced fotigue. By
understanding what to expect and how patients may be affected, the patient and their
significant others are emotionally, physically, and psychologically better prepared to
manage this challenge. Patients need to understand fatigue and also what actions they can
do to control or eliminate chemotherapy induced fatigue.
Research studies have documented that fatigue is a common side effect of
chemotherapy. A review o f the literature revealed few studies that focus on nursing
interventions that may prevent or minimize fatigue. Pickard-Holley (1991) described and

defined fatigue by focusing on the individual experience. Other research compares
depression and fatigue, the energy used to cope with these issues, (Beck, 1967) and how
the caregiver is affected (Jenson & Given, 1991).
According to Love, Leventhal, Easterling andNerenz (1989) nausea, hair loss,
and tiredness were experienced by at least 80% of patients receiving chemotherapy, and
46% of these patients consider discontinuing therapy by the sixth cycle. The researchers
conclude that treatment side effects may be more effectively managed if techniques in
controlling them were taught to patients prior to initiation o f their treatment
Providing patients with adequate information may help them establish selfcare measures prior to the occurrence o f side effects (Shane, 1996). Dood (1983)
examined; vdiether patients practice self-care, whether patients instructed in side effect
management techniques (SEMT) adopt them, and v teth er information on SEMT, given
alone or in combination with other information (e.g., medications), "elicits differential
self-care behavior" (p.63/ Research revealed that patients who received SEMT
information practiced more se lf care behavior than patients who received no self-care
behaviors. The stuify identified other advantages for patients who were provided with
SEMT such as: less burden fiom depression, difficult concentration, pain, and less
extension o f side effects burden (Longman, et al., 1997). Longman further implies the
importance for the oncology nurse in providing SEMT which may improve the cancer
patient’s ability to manage the side effects o f chemotherapy.

Problem

Existing research supports the seriousness o f fetigue as a side effect o f
chemotherapy for the oncology patient Various organizations such as the North
American Nursing Diagnosis Association (NANDA) and the Oncology Nursing Society
through Fatigue Initiative Research and Education (FIRE), support the need for further
research on fetigue m relationship to the effect on patients. The purpose o f this study was
to examine the level o f patient adaptation to chemotherapy-induced fatigue when fatigue
management stalls are tar%ht by oncoloQr nurses.

CHAPTER:
REVIEW OF THE LITERATURE AND CONCEPTUAL FRAMEWORK

Literature Review
Oncology nurses are specialists who deal with numerous problems
experienced by patients during their battle with cancer and its treatm ent Most cancer
patients experience chemotherapy-induced hitigue, and many hours o f research have
been dedicated to discovering methods to help patients combat this debilitating side
effect
Based upon a review o f literature, three main categories related to fatigue will be
addressed: a) fatigue as a common effect of chemotherapy, b) patients efforts to
counteract chemotherapy related Gttigue, andc) nursing interventions for fatigue.
Fatigue as a side effect o f chcmotherapv. Research suggests that chemotherapy
related &tigue is one o f the most common and challenging symptom management
problems for patients and nurses. According to the Oncology Nursing Society (1997),
fatigue experienced by a person with cancer doing chemotherapy is different from the
fatigue of everyday life. Cancer treatment fatigue can appear suddenly, be overwhelming,
may not always be relieved by rest, and can persist after treatment ends. Fatigue from

chemotherapy is real and cannot be ignored. Helping to relieve chemotherapy-induced
fatigue has the potential to preserve and improve the quality o f life for cancer patients.
In a descriptive, cross-sectional stu<fy on fatigue, Pickard-Holley (1997),
compared 12 adults with ovarian cancer to 12 healthy adult women. The relationship
between severity of fatigue, age, stage o f disease, course o f treatment, and CA 125
(tumor marker that may be suggestive to the degree of disease) were measured. The
research found no significant relationship between httigue and age, stage o f disease,
course o f treatment, or depression. Weak to moderate relationships were found between
levels o f fatigue and CA 125 levels. According to these results, a moderately strong,
(r = .68, p < .01) relationship was found between ratings on the Rhoten Fatigue Scale
(RFS), an ordinal scale that subjectively quantifies present fatigue, and fatigue items on
the Beck Depression Inventory (BDI). As the tumor burden increased so did the fatigue
that the patient experienced. The researchers recommended additional research to stutfy
the relationship of fatigue over the entire treatment plan for the cancer patient, and
expanded stwty of die relationship between fotigue with all types o f cancers on both
males and females.
A qualitative stucty conducted by Hilfinger, Messias, Yeager, Dibble, and
Dodd (1997) explored the experience o f fatigue among patients undergoing
chemotherapy. One hundred twenty-seven adult patients who began their first course of
chemotherapy were selected to participate firom 18 treatment centers in California. Data
was collected through individual open-ended interviews using grounded theory
techniques.

The analysis revealed several major categories related to chemotherapy
induced fatigue: a) being tired, b) effect on well-being, c) attribution o f origin, d)
awareness and expect, e) emotional reactions, f) activity, g) "biggest" concern, and h)
strategies and plans. The results o f the study suggested that nurses must consider
chemotherapy-induced fatigue within the context o f a patient's life and environment
when planning care. Furthermore, the findings supported the need for nurses to listen and
evaluate subjective experiences o f patients when planning therapeutic nursing
interventions.
Berger (1998) used a prospective, descriptive design to study 72 women
receiving chemotherapy after surgery for breast cancer. The Piper Fatigue Scale (1989)
was administered 48 hours after each chemotheraity treatment for three cycles of
chemotherapy and at three midpoints between treatments. Significant differences
between fatigue scores at the time o f treatment and at the midpoint intervals were found
(F = 6.07, p = . 016. Overall, 12 o f 14 women in the stu<ty reported high fatigue levels at
each of the three midpoints compared to fatigue at only one point during the treatment
This study was significant in that it demonstrated the "roller-coaster pattern" of fatigue,
and supported the importance o f developing and testing nursing interventions to modify
such experiences.
Patients methods to counteract fatigue. Patients who experience chemotherapyinduced fatigue may actively attempt to alleviate or manage their fatigue. Richardson and
Ream (1997) and Longman, Braden, and Mishel (1997) have described a number o f these
measures. Patients living with the demands of chemotherapy often develop a new

repertoire o f skills and knowledge that assist in the management o f chemotherapeutic
side effects. These new skills enable patients to adapt to their treatment and to manage
other side effects experienced, including &tigue.
In a longitudinal, correlational stucty conducted by Richardson and Ream
(1997), selfeare strategies used by patients receiving chemotherapy were examined. The
focus o f the research was to determine the fiequency o f self-care actions, evaluate the
effectiveness of these actions, and examine the relationship between fatigue and the
performance of self-care. A sample o f 109 subjects were asked to keep a record of their
symptoms in a diary. The results o f the stucty found that 89% o f the subjects documented
experiencing fatigue at some point Statistical comparison o f the fatigue experienced
revealed that patients receiving a 2 1-day regimen of chemotherapy were significantly
more fatigued (p< .05) than those receiving a 28-day or a weekly chemotherapy cycle.
Despite the incidence o f fatigue, the researchers reported that self-care actions were only
initiated on one-half of the days (49.0%) that the symptoms were reported.
Findings also revealed that 80% o f the time patients only performed one action a
day in an attempt to combat fatigue. However, the patients in this study used 31 different
self-care action measures to relieve their chemotherapy-induced fatigue. The most
commonly used technique was modification o f activity and rest patterns. Yet, these selfcare activities proved to be largely ineffective, providing only partial relief of
chemotherapy induced fatigue only 53.7% o f the time. No relief o f chemotherapy
induced fatigue was reported by over 9% o f the subjects.
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Overall, the symptom diary provided an effective approach for data collection
in this study (Richardson & Ream, 1997). As chemotherapy programs become more
sophisticated and complicated, fatigue continued to be the number one problem for
patients. The self-care measures that the oncology nurse offered to these patients can be
an effective way to control chemotherapy induced fatigue.
Fiffy-three adult women with breast cancer were assessed in a study by
Longman, et al. (1997) that described the chemotherapy side effect burden experienced
over time. Longman appraised the association o f side-effect burden with self-care and
self-help. Data obtained for the Self-Help fotervention Project (SHIP) was used to test the
effectiveness o f interventions for women receiving treatment for breast cancer. The
selected intervention was designed to facilitate self-help rather than a dependent
response. Interventions included educational classes for the patient and support by the
nurse. Researchers gathered data at three designated points in time: a) after the medical
treatment, b) 6 weeks later, and c) 3 months later. According to Longman et al., fatigue
was the most frequent and problematic side effect over time. "Side-effects burden" was
measured and showed a significant improvement in adaptation with self-help over time.
A reduction in self-help was associated with symptom extension (t= 0.42; p<. 002). The
insights gained from this analysis support that engaging in more self-care activities
causes fewer burdens from chemotherapy-induced side effects including fatigue. The
study supports the need to individualize nursing interventions for each patient to reduce
chemotherapy induced fatigue

Nursing interventions for fatigue. Nursing is responsible for identifying and using
research-based assessment techniques to facilitate effective treatment for chemotherapyinduced fatigue. Providing patient education materials containing specific information
can be an effective nursing intervention. Knowledge about side effects such as fatigue
may empower patients and encourage them to become an active participant in their own
care (Skalla & Laçasse, 1992). Fatigue management strategies are aimed at assisting
patients to participate in the lifo activities that they find most important. According to
this researcher nursing intervention is essential in this area and must take a proactive role
in assisting the patient to learn measures that may ease their sensation o f fatigue.
Teaching should reflect the current experience o f the patient with the disease and
treatment as well as her understanding of the principles o f daily energy expenditure,
conservation, and restoration (Skalla & Reiger, 1995).
Many researchers have identified the causes o f fotigue, but few have tested
nursing intervention measures. O f those studies that have addressed intervention focused
on three categories: education, exercise, and attention-restoring activities (Clark & Laces,
1998).
Skalla and Laçasse (1992) studied patient education regarding fatigue. Though
fatigue is a frequent complaint o f patients undergoing cancer treatment, specific self-care
activities are seldom addressed in patient education material. To fill this void, the
researchers developed an education tool that nurses should be able to use with a special
emphasis on the management o f fatigue. Currently this tool is in progress o f evaluation
with a large population o f oncology patients (Oncology Nursing Forum, 1992).
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Schwartz (1998) examined the physical activiQr patterns o f cancer survivors who
identified themselves as athletes. The purpose was to assess how much exercise athletic
patients with cancer engaged in during treatments. In addition^ this stucfy^ sought to
determine how cancer-related fatigue affects the abili^ of the athletic patient to exercise,
and determine common problems and patterns associated with fatigue. A cross-sectional,
descriptive shufy was conducted among 219 cancer survivors who responded to a call in
four major sports magazines. According to the stucfy^, the majority^ o f respondents were
physically active during their treatment Sixty-nine percent of the respondents continued
to be active, but modified their exercise programs. However, 52% described their fatigue
as affecting their entire bocty, and 26% expressed fotigue before exercise. According to
the respondents, balancing exercise and rest was the most commonly used strategy for
managing their symptoms (p = .041). Respondents with breast cancer reported less
cancer related fatigue (CRF) after exercising (p^ .003). The implication for nurses
regarding patient instruction o f CRF is that nursing intervention will support and educate
patients on the importance o f rest and exercise for the management o f fatigue.
Mock et al. (1997) conducted an experimental stutty in which they compared
the levels o f physical, functional, and symptom intensity of women in a walking exercise
program during radiation treatment They compared this to women who did not
participate in exercise. A pretest and posttest was administered to each group. Findings
revealed that the exercise group scored significantly higher than the control group on
physical functioning and symptom intensity (p= .003), including fatigue, anxiety, and
sleep disturbances. Moreover, fotigue was the most frequent and intense subjective
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symptom reported. The authors concluded that, nurse-prescribed and monitored exercise
is an efTective, conventional, and low-cost self-care activi^ that reduces symptoms and
facilitates adaptation to breast cancer treatment.
Graling (1998) examined [Aysical function and symptom intensity in women
with breast cancer. The sample consisted o f 46 women with stage I and H breast cancer
who participated in a walking exercise program during radiation therapy. Using the
multiple analysis o f covariance (MANCOVA), the results revealed a significant
difference between the two groups with plgrsical function and symptom intensity
outcome (p< .001). The findings demonstrated benefits fiom walking exercise programs
with improved physical and psychological functioning in the experimental group. The
"concept o f the person achieving adaptation through integrated physical and psychosocial
modalities relates adaptive responses illustrated by women who exercise regularly and
exhibited higher levels o f functioning and decreased fatigue" (Graling, 1998, p.275).
hi summary, a review o f the literature suggests that the nursing profession can
influence patients' perception and management of fatigue. Nurse scientists need to
explore the phenomenon o f fatigue through increased research. Although much literature
has focused on understanding fatigue, few studies have tested nursing interventions
designed to combat this prevalent and destructive symptom. Studies designed to evaluate
nursing interventions often have small, heterogeneous samples that reduced the
generalizability o f the findings (Shane, 1996). Though these studies contribute valuable
information to the know ler^ o f fiitigue, further research is needed to examine what
nursing intervention may have on chemotherapy-induced fatigue, what age group would
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best be affected by nursing intervention, and whether regular supervised exercise would
create an effect on fatigue.
Conceptual Framework
A number o f frameworks or models have been proposed to explain the underlying
mechanisms o f chemotherapy-induced fatigue, but this researcher feels that Piper’s
Integrated Fatigue Model is practical for the use with the oncology patient The Piper
Integrated Fatigue Model (1995) suggests that fotigue is multidimensional and is the
result o f alteration in biochemical, physiological, and behavioral factors. The Piper
model helps to delineate objective and subjective indicators o f fatigue which guides
nursing assessment. It provides a framework for the clinical approach that embodies
practical tools Q^eum, 1997).
According to Piper (1987,1989, & 1995) assessing fotigue is the key to
establishing management strategies for the patient, family, provider, and health-care
system. As a result. Piper developed an instrument to assess the five dimensions of
fatigue, including: temporal, sensory, cognitive-mental, affective, and behavioral.
The objective dimension of fotigue includes the signs o f fatigue that can be validated by
physiological, biological, and behavioral means. While the subjective dimensions of
fatigue include, a) perception about timing of fatigue (temporal), b) the mental, physical,
and emotional symptoms of fatigue (sensory), c) the emotional meaning attributed to
fatigue (affective dimension), d) the impact and distress fatigue might have on activities
of daily living (intensity) (Piper et al., 1987,1989).
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The temporal dimension of üitigue is linked to a patient’s 24-hour circadian
patterns. For example, do patients have more energy at the end o f the day or any
particular time o f the day? Understanding answers to this question may give health
providers clues in differentiating acute from chronic fatigue. Such findings supply health
care providers with interventions that are appropriate to help treat fatigue.
Symptoms a patient describes when defining tiredness are referred to as the
sensory dimension o f fetigue. Questions that need to be answered in this dimension fi)cus
on location and intensity. The fatigue may be localized in a specific muscle group for
example, in the eyes, legs, or other areas o f the body. This fatigue may also vary in
severity.
The cognitive-mental dimension o f fatigue is defined as a loss o f concentration
and a decrease in memory or alertness. The underlying mechanism o f this dimension can
include neurotransmitters in the central nervous system that are being triggered by the
inflammatory response associated with many chemotherapy treatments (Piper, 1997).
The affective dimension o f fatigue includes distress, irritability, impatience, and
lack of motivation. Some research has been done to examine the relationship of
depression and fatigue. Smet and colleagues (1995) from the Netherlands determined
that there was no correlation between depression and fatigue, thereby helping to
differentiate the two symptoms.
Finally, the behavioral dimension of fatigue may be described as a dimirushed
activity level. Patients may take longer to perform activities or feel that they are not
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capable o f performing routine tasks. According to Piper, the documentation o f daily
living has been used to help researcher capture the essence o f this dimension.
The following diagram illustrates Piper's Integrated Fatigue Model (1995)
framework for the conceptualization o f fatigue in the healthy and clinical population.
Figure Example L Piper’s Integrated Fatigue Model

Integrated Fatigue Model
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As the integrated model appears, the center of the framework is the subjective
(perceptual) and objective (physiological, biological, and behavioral) indicators of
fatigue. Surrounding the subjective and objective areas are the metabolic,
neurophysiological, situational, and developmental patterns. The model brings into being
the signs and symptoms of fatigue experienced by patients receiving chemotherapy. Piper
acknowledges the signs and symptoms may also be a result o f the accumulation o f
various metabolic wastes, such as uremia. A change in energy production secondary to

15

anemia, thrombocytopenia, and the build o f waste products creates fatigue. Piper (1997)
also describes other factors that result in fatigue that is experienced by patients receiving
chemotherapy such as cachexia, anorexia, and various metabolic imbalances.
Alterations in activity and rest patterns can play significant roles in the
prevention, cause, and alleviation o f fatigue. Unnecessary sedentariness, prolonged
bedrest, and immobilization contribute to weakness and fatigue. Chqrgenation patterns are
affected by fatigue as a result o f skeletal muscle loss. More oj^gen is required as a result
of the lost oxidative capacity o f unconditioned muscles. This factor can contribute to the
development o f fatigue and is one o f the reasons why aerobic endurance exercise is often
prescribed (Piper 1997).
Sleep-wake patterns can influence fatigue. Lack o f restful sleep at night can lead
to increased sleepiness and fatigue during the day. Daytime fatigue increases the need for
daytime napping and increased n i^ttim e sleep (Piper, 1987). Various disease states,
medical therapies, and symptom management may temporarily exacerbate fatigue
however, effective symptom management should eventually improve it. Any factor that
alters or interferes with the ability to maintain adequate oiqrgen levels, such as anemia,
can produce fatigue. Fluid and electrolyte imbalance and changes in neurohormone
levels, such as melatonin and serotonin, can also affect neurotransmission and thereby
result in fatigue.
Psychological factors such as responses to stressors, depression, boredom, beliefs,
and attitudes can further fatigue. Environmental problems, life events (pregnancy,
parenting, and divorce), and innate host Actors such as age, sex, race, and genetic make
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up also affect the development o f fatigue. Psychological factors and social patterns, such
as perceived quality and amount o f social support, cultural beliefs, and economic factors,
may also influence fatigue.
Piper’s Fatigue Scale (PFS) correlates directly with the Piper Fatigue Integrated
Conceptual Model. The PFS is composed o f 22 numerically scaled “0 to 10” items that
measure the four dimensions o f subjective fatigue. These dimensions are measured in
four categories behavioral (6 items), affective meaning (5 items), sensory (5 items), and
cognitive/mood (6 items).
The PFS will be the standard o f measurement for this research stu<ty. Patients will
be given this assessment questionnaire as a pretest (prior to nursing instruction on
methods the patient may use to help manage chemotherapy-induced fatigue) and a post
test. Piper’s integrated model on fatigue gives clear evidence that fatigue is a complex
multicausal and multidimensional sensation that requires investigation and intensive
research. Oncology nurses must understand the implication that fatigue has for their
patients and what measures they can take to assist in managing this complex problem.
Piper’s Integrated Fatigue Model will be the framework for the stutty and the PFS will be
used to measure fatigue as experienced by patients receiving chemotherapy.
Significance of the study. Further study o f the fatigue phenomenon in cancer
patients is warranted to improve the quality o f life in this cancer population. Patients,
when starting chemotherapy, may be unprepared for the severity of fatigue th ^ may
experience and often lack the knowledge o f the appropriate measures to help alleviate
fatigue. From a nursing perspective, it is important to assist patients in the management
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of their disease and treatment Nurses caring for cancer patients, perhaps more than any
other profession, have a unique opportunity^ to stutty and influence quality o f life
outcomes related to fatigue. As nurses respond to the challenge, patients will benefit
from the effort and fatigue wiU become m angeable. Empirical testing of specific nursing
interventions needs to continue. This study strives to add to the body o f nursing
knowledge regarding fotigue and related nursing interventions.
Research Question
What role does early nursing intervention have in adaptation to chemotherapy
induced fatigue?
Research Hvrothesis
The experimental groiq) that receives early nursing instruction that will help
them to adapt to chemotherapy induced fatigue will score lower on Piper’s Fatigue
Assessment scale than those patients who receive the standard nursing instruction on
chemotherapy.
Kev Terms
1. Early nursing interventions is instruction that is provided to the patient/Tamüy
prior to their initial chemotherapy treatment thus enhancing the patient's knowledge of
coping mechanisms and facilitating adaptation.
2. Fatigue is a subjective feeling o f tiredness that is influenced by circadian
rhythm. Fatigue can vary in unpleasanmess, duration, and intensity. When acute, fatigue
serves a protective function. When fatigue is excessive or chronic, its function is

18

unknown" (Piper etal., 1989, p.200). In this stucfy the Piper Fatigue Scale will measure
fatigue.
3.

First-time chemotherapy patients are recently diagnosed cancer presenting to

the outpatient chemotherapy clmic to receive new chemotherapy.
Kev Concepts
1. Adaptation is a change in structure, function, or form that produces better
adjustment o f a person to his/her environment (Guialink, 1980, p. 15) as measured by the
PFS.
2. Acquired coping mechanisms are learned behaviors that facilitate adaptatioiL
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CHAPTERS
METHODS

Etesian

This study ex am in é the effect of early nursing interventions on the ability of a
patient to adapt to chemotherapy induced fatigue. The intervention consisted of
suggested methods that could assist patients with adaptation to fatigue. Using a
convenience sample, subjects were randomly assigned to an experimental or a control
group. A pre test and post-test were given to subjects in the intervention and control
groups to evaluate the success o f the nursing intervention. Subjects were given the pre
test on the first day o f their initial chemotherapy treatment and again during the sixth
week of the chemotherapy cycle.
Setting
Subjects were selected from five private oncology and hematology offices that
administer chemotherapy to their patients. These offices were located in Southwestern
Michigan. Each office had individual rooms where the physician could examine the
patients, and this room was available to be used by patients to complete their assessment
form. Chemotherapy treatment areas were located in one centrally located area, and
patients sat in lounge chairs where they were able to participate in conversation with
other patients. This was the area where patients completed their fatigue assessment tool.
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[f the patient had concerns regarding the privacy of this area, they had the opportunity^ to
be moved to a private exam room.
Sample
A convenience sample o f 30 subjects was initially sought for this study. Five
months into data collection, limited recruitment o f subjects, seriously affected the
completion o f the stu<fy. This resulted in a decision to decrease the desired sample size to
15 subjects.
Subjects for this stu<ty met the following criteria: a) recently diagnosed with
cancer or having been di^nosed with new cancer or recurrent cancer in the past three
months and requiring chemotherapy at the ofGce; b) 18 years or older; c) and able to read
or write English. Subjects uiio received concomitant chemotherapy and radiation for the
treatment of their disease were ineligible to participate in this project
While the deshed sample was 15,16 subjects participated in the study. The
intervention group contained twelve subjects, and the control group had four subjects.
The difference in the number of subjects entered into the control and intervention group
was a result of the inconsistency among the five nurses and among five different ofBces
that distributed the data collection packets. Although a distribution protocol was
developed for random assignments, more even numbered (intervention group) packets
were given to the subjects involved in the study than odd numbered (control group)
packets.
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Instrument
The revised Piper Fatigue SelF-Report Scale (PFS) was used to measure the
phenomenon o f fatigue experienced by cancer patients in the study. The original PFS
existed in two forms, a baseline form (PFS-B) and the revised PFS-C. The PFS-B was
designed to measure usual patterns of fatigue and any changes experienced during the six
months prior to a medical diagnosis or the start o f treatment (Piper et al., 1989, p.200).
The revised PFS determines httigue patterns "now” or "for that day" and can be selfadministered. Fatigue symptoms were measured using a “0-10” numeric scale.
The PFS in its current form was composed o f 22 numerically scaled, ”0 to 10”
items that measured four dimensions o f subjective fotigue, bebavioral/severiQr (6 items),
affective meaning (5 items), sensory (5 items), and cognitive/mood (6 items). These 22
items were used to calculate the four-subscale/dimensional scores and the overall fotigue
scores. Five additional items (#1 and #24-27) were not used to calculate subscale o r total
fotigue scores, but were recommended to be kept on the scale as these items furnished
rich, qualitative data. To calculate the total fatigue score, the 22 items were summed and
divided by 22 in order to keep the score in the same numeric "0 to 10" scale. The higher
the score, the greater the fatigue experienced by the subjects.
According to Polit and Hungler (1995), reliabili^ is the degree o f consistency
with which an instrument measures the attribute it is suppose to measure. As such,
coefficients greater than .70 are considered acceptable for group comparison (Polit &
Hunger, 1995). Previous studies using PFS had established reliability^ coefficients a t .97
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for the total scale and ranged between .92 and .95 for the subscales. For this stu<fy,
reliability for the subscales was between .90 and .94. Similar to previous studies, the total
scale reliability^ was .97 for this investigation (Table 1).
Table 1
Reliabilitv Analvsis
Scale

Number
o f items

Piper
(1997)

Baker
(1999)

Sensory

5

.95

.91

Affective

5

.95

.93

Cognitive

6

.92

.90

Behavior

6

.92

.94

Total PFS

22

.96

.97

Human Subjects Considerations

Permission was received from Piper to use the PFS (Appendix B). Participating
oncologists signed a permission letter, allowing the PFS to be given to their patients
(Appendix C). Approval was received fi’om the Grand Valley State University Human
Subjects Review Committee to conduct the stucty (Appendix D).
Procedure
Each office participating in the stucty had a designated oncology nurse who
agreed to explain the procedure and assist with administering the assessment tool. The
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designated nurse was trained to administerthe tool. Forty patient packets were prepared,
the odd numbered packets had the demographic (Appendix E), a cover letter (Appendix
El, and the fatigue assessment tools (Appendix G). The even numbered packets had the
above listed material as well as the fatigue intervention material (Appendix IQ. The
packets were distributed 1-5,6-13,14-25,26-30, and 31-40 respectively to the offices
that were participating in the stu<fy. The packets were randomly given to the first 16
patients who met the criteria were entered into the study.
The researcher kept a running master list with four columns that included the
study number and assigned group as well as the patient’s name and telephone number. At
the completion o f the stu(^, the master list was destroyed. The following outline
identified the specific method in which this was accomplished.
I. The researcher provided an inservice for the designated oncology nurse for the
purpose o f orienting them on eligibili^ o f patients for the study, demographic forms, and
the timing o f the Piper Fatigue Scale ^F S ) (Appendix G).
n. Manila envelopes, numbered 1-40, were distributed to the offices and located
in a convenient area for the oncology nurse. The envelope contained the following:
A. Pre-test PFS with self-addressed envelope for the patient to return the test
to the researcher.
B. Demographic form
C. Fatigue Management Education material (in even numbered envelopes)
D. Post-test (PFS) with a self-addressed envelope for the patient to return the
assessment tool to the researcher.
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Steps A, B, and C were completed after the patients meet eligibility and agreed to
enter the study. This was on the first day o f their first course o f chemotherapy. After
completion of these forms, th ^ were placed in a sealed self-addressed envelope and
mailed to the researcher.
m . The PFS was placed in a self-addressed envelope and sent home with the
patient with a date for completion and return to the researcher.
IV. The logbook was placed in secured location accessible to the registered nurse
and the researcher had access to i t The following information was entered into the log on
each patient
A. Number assigned to the subject
B. Name o f the subject
C. Telephone numbers o f each subject.
V. The odd numbered patients were assigned to the “control group” and the even
number subjects to the “intervention group”.
VI. Following the subjects’ acceptance to enter the study, consent to participate
was indicated by the subject reading the cover letter and proceeding with the completion
of the demographic form and with the pretest PFS.
VH. Upon the completion o f the forms, the intervention group subjects reviewed
the Fatigue Management Education material. Any questions about the material were
answered.
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v in . The post-test PFS was completed during the sixth week o f the chemotherapy
regimen. It was completed at the patient’s home and sent to the researcher in the
provided self-addressed envelope.
IX. The log and any subject specific data were destroyed to optimize
confidentiality following the completion o f the study.
X The staff at the oncology ofGces were given a snack and beverage at the time
o f the inservice and the oncology nurses were given a small gift o f appreciation at the
completion o f the stucty.
The researcher was available to answer any question that the nurses or
patients had regarding the tool or study at any time. After the inservice was given to the
oncology nurses, there were no questions directed to the researcher by the subjects who
entered into the study.
Fatigue M anagement Intervention
The intervention presented to the subjects in the study was a combination o f a
brochure distributed by a pharmaceutical company on “Fatigue” and an assortment o f
measures that could be utilized by the subjects to help adapt to chemotherapy-induced
fatigue developed by Skalla and Laçasse (1992). Specifically, the materials suggested
methods that used less e n e r^ and could result in more energy for the activities that were
o f greater importance to them. Many o f the ideas came fiom other patients with cancer
that used these interventions to help cope with fatigue (Appendix H).
Ortho Biotech, pharmaceutical company, offered booklets entitled “Dimensions
o f Caring, Taking Control o f Fatigue”. These booklets offered a description of fatigue
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and how to better understand i t They described why patients felt fatigue while
undergoing chemotherapy and suggested keeping ajournai o f their level o f fatigue, as
well as making a list o f activities and the level o f importance to them. Specific
suggestions included learning to pace activities, getting plen^ o f rest without overdoing
the length of the rest period were identified strategies within the brochure. Delegating
specific activities and responsibilities to others in order to conserve energy were also
si^gested. Other suggestions included reading, relaxing or listening to music was helpful
in managing fatigue. Eating and drinking a balanced amount was crucial in helping adapt
to chemotherapy-induced fetigue.
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Chapter 4
DATA ANALYSIS
Technique
The purpose of this study was to examine the fatigue level o f patients while
undergoing chemotherapy for the treatment o f their cancer. The research hypothesis was
that the experimental group which received the Fatigue Management Education would
experience lower levels of chemotherapy induced fatigue than those patients who receive
the standard nursing instruction on chemotherapy.
Data were analyzed using the Statistical Package for Social Sciences. A
significance level of p < 0.05 was set for all statistical procedures. Descriptive statistics
were used to characterize subjects in this stu<fy. In order to determine if there was a
significant difference in the level o f fatigue o f the control and intervention group o f
subjects an independent t-test was performed.
Characteristics o f the Subjects
Prior to evaluating the effects o f the intervention on fetigue, the demographic
characteristics o f the subjects were compared The demographics characteristics included
age, gender, type of cancer, and treatment. In addition, the subjects’ previous cancer
history, type o f residence, number o f persons living with each subject and how much
support persons th ^ could count on was assessed.
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The sample was comprised o f 16 subjects and 10 females. Gender was equally
distributed among subjects in the intervention group. All four subjects in the control
group were females. O f the four subjects in the control group, two were less than 40
years old, and one was the age o f 61 years. In contrast, the majority o f the subjects in the
intervention group were between the age o f 61 and 90 years (n=8). This age comparison
is presented in Table 2.
Table 2
Age Comparison

Ages
Categories

Total group
n (%)

Control
n
(%)

Intervention
n (%)

22-40

5

(31.4)

2

(50.0)

3

(24.9)

41-50

2

(12.6)

1

(25.0)

1

( 8-3)

51-60

1

( 6.3)

0

(00.0)

0

(00.0)

61-70

4

(25.1)

1

(25.0)

4

(33.3)

71-80

3

(18.8)

0

(00.0)

3

(25.0)

81-90

1

( 6.3)

0

(00.0)

1

( 8.3)

All subjects in the study (n=16) lived in a private home (100%). This
indicating that all subjects had some degree o f responsibili^ of maintaining their
homes. Within the intervention group, 12.5% o f subjects lived alone while all
members o f the control group had at least one person living with them. The mean
number of persons living with each o f the subjects was 2.12 (SD= 1.58). Most
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subjects (87.6%) were able to rely on support from persons living with them for
everyday tasks such as, meals, errands, and household needs. Two subjects in the
intervention group (16.7%) lived alone and had no one available for support. For
the total group the mean value o f persons available for support was 1.93 (SD=
.25). These results are presented in Table 3.
Table 3
Household Members and Available Support
Number o f people living
with the subjects

Number o f support
with the subjects

Mean

SD

Mean

SD

Intervention

1.83

1.52

1.58

1.24

Control

3.00

1.63

2.25

0.95

The intervention group had a mean value of 1.58 (SD= 1.24) for the number
o f persons that the subjects could count on for support In contrast the control
group described a mean value o f 2.25 (SD= 0.95) for support persons that were
available to them on a daily basis. Thus the intervention had less persons living
with them, also having fewer persons available to assist them with daily chores.
In summary, individuals within the intervention group bad a fewer number
o f individuals available to provide emotional, physical, and spiritual support
which may have added to the level o f fatigue experienced by this group.
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Subjects within the study received a varied o f chemotherapy regimens for
treatment of their cancer. While the control group subjects had four different types o f
cancer diagnosis, the majority o f the intervention group subjects were diagnosed with
cancer of the breast, blood, and lymphatic system. These results are presented in
Table 4.
Table 4
Cancer Diagnoses
Types
o f Cancer

Control
N (%)

Intervention
n (%)

Breast

1

(25.0)

3

(25.0)

Colon

1

(25.0)

1

(8.3)

Lymph

1

(25.0)

2

(16.7)

Blood

0

(00.0)

4

(33.3)

Pancreatic

1

(25.0)

0

(00.0)

Testicular

0

(00.0)

2

(16.7)

All subjects were assessed for the number and types o f services received in the
home environment. Only one individual in the control group received some type of
service in the home, compared to nine (75%) subjects in the intervention. O f the
responders in the intervention group, one received meals on wheels, five received some
form of home nursing services and two subjects used oxygen.
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Data Analyses
Although subjects had been informed o f the importance o f completing the entire
survey, missing data was still apparent Following recommendations provided by Polit
and Hungler (1995) for handlmg missing data, the missing responses in the study were
assessed for random or systematic error. Once it was identified that it was random, the
statistical item mean was substituted for the missing values among subjects who
answered at least 75% o f the remaining items on that particular subscale. The strategy
^ as congruent with Piper's (1997) scoring procedure.
Piper’s Fatigue scale composed o f 22 numerically scaled items was divided into
four dimensions o f subjective fatigue: a)behavioral/severi^, b)affective/meaning, c)
sensory, d)and cognitive/mood These 22 items were used to calculate the four
subscales/dimensions and the total fatigue scores.
Total fatigue scores. The subjects’ fatigue level was assessed prior to the
initiation o f their treatment and again six weeks into their treatment The control group as
a group was less fatigued at the start o f their treatment than the intervention group. The
pretest fatigue levels o f the control group ranged firom 2.32 to 4.64, with a mean o f 3.82
(SD = 1.05). In comparison, the fatigue level o f the intervention group ranged fiom 0.41
to 7.00 (M= 4.45; SD = 2.13). The intervention group had four subjects that reported
fatigue levels at the initiation of the study at 5.23 o f higher. While no one in the control
group listed a fatigue level above 4.64.
Fatigue levels of the control group at the six-week follow-up ranged fiom 2.59 to
6.36 (M = 5.01; SD = 1.67). Following the Fatigue Management Education, the level o f

32

fatigue was assessed among the intervention group. According to these subjects, their
fatigue ranged from 1.36 to 8.41, with an average fatigue level o f 5.39 (SD = 2.26).
An independent t-test was performed to compare the differences in the level of
fatigue experienced by the intervention and control groups. The results revealed that
there was no significant difference on the degree o f fatigue experienced by the subjects
prior to the implementation o f an intervention or after the intervention was initiated.
Therefore, the research hypothesis posed in the study was that the experimental group
which received the Fatigue Management Education would experience lower levels of
chemotherapy induced fatigue than those patients who receive the standard nursing
instruction on chemotherapy was not supported. These results are presented in Table 5.
Table 5
PFS Scores
PFS

hitervention
Mean (SD)

Control
Mean (SD)

Pretest

4.45 (1.05)

3.81 (2.13)

Posttest

5.39 (2.26)

5.01 (1.05)

t

<Lf.

P

-.56

11

.58

-.30

12

.77

Results of the post-fatigue scores for both groups indicated that the intervention
(nursing instructions on methods to help patients adapt to fetigue) did not have a
significant effect on the level o f fatigue six weeks after the start o f treatment. A lower
score on the post-fatigue test o f the intervention group may have been indicative that the
nursing intervention affected the level o f fatigue.
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Fatigue dimension scores. To determine if differences in the level o f fatigue
existed among the four dimensions paired t-tests were performed. The four dimensions
included in the paired t-test were sensory, cognitive, affective, and behavioral. No
significant differences were identified over time for either the intervention or control
group.
Other findings. Additional analyses using Pearson’s r correlation was
performed to examine the relationship between levels o f fatigue that subjects
experienced, their ages, and the amount o f support th^r received from the individuals
living with them. Only one significant relationship was identified between age and
the number o f individuals available for support (r = -.56; p =.02). According to this
finding, as the subjects increased in age less support was available to them.
A t-test for independent samples o f sex (male vs. females) in relationship to their
pre and post-fatigue scores were analyzed. The fatigue scores indicated that the females
were initially more fatigued than the males in this study. Similarly, the posttest
assessment revealed that the females continued to experience higher levels o f fatigue
than the male six weeks into their chemotherapy treatment (Table 6).
Table 6.
Comparison o f Males and Females Fatigue Scores (N = 16)
PFS

Males (n = 4)
Mean (SD)

Females (n = 12)
Mean (SD)

Pre-fatigue

2.97(2.22)

Post-fatigue

4.51 (2.23)

t.

d f.

P

4.82(1.43)

-1.83

11

.09

5.59 (2.01)

-0.88

12

.39
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Subjects self-repocted specific causes o f fatigue and measures they used to assist
in relieving fatigue. Chemotherapy was the most commonly cited cause o f fatigue.
According to subjects, the primary methods used to help alleviate fatigue were rest,
limiting activity, sleeping, and watching nature.
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CHAPTERS
DISCUSSION AND IMPLICATIONS
Discussion
The purpose o f this study was to examine the role o f Fatigue Management
Education in facilitating adaptation to chemotherapy-induced fatigue. According
to the results o f this stucfy, the research hypothesis was not supported. The
subjects did not experience significant reductions in the level o f fatigue following
implementation of the intervention. While the results did not support the
hypothesis that the intervention would be effective in this study, a larger sample
and stronger nursing participation in the presentation of the Fatigue A/hmagement
Education may strengthen the stwfy and find support for the effectiveness o f the
intervention.
Interesting and important information for future research did emerge fi^om
the data Although the Fatigue Management intervention did not play a factor in
the level o f fatigue experienced by the two groups, the age o f the subjects and the
availability of support persons appeared to influence the degree o f fatigue. The
mean age for the control group was 45.0 years old (SD = 11.83) and the
intervention group mean was 59.9 years old (SD = 19.2). The data revealed that
older subjects have less support persons available which may have influenced the
fatigue level o f the intervention group.
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Prior research supports that the availability o f support and the age o f
subjects directly effects the health o f the individual receiving chemotherapy (Nail^
1999). Irvine, Vincent, Graydon, and Bubela (1998) reported a correlation
between age and fatigue. More specifically, Vincent et al. found that the older the
subject, the higher level o f fatigue at their final assessment (r= 0.21, p <0.05).
While there was not a relationship identified between the subjects' age and their
levels of fatigue in this study, it is possible that these results may have been
influenced by the sample size.
According to Dood (1983), education of fatigue management and adequate
information regarding self-help measures were valuable in helping subjects deal
with the side effects o f chemotherapy. Dood’s research indicated that information
was not enough to influence fatigue in subjects receiving chemotherapy. Other
measures were identified that could offer assistance to subjects in dealing with
fatigue. More specifically, these measures were fewer burdens fiom depression,
controlling pain, and less extension o f other side effects from the treatment
Although depression was not measured in this stutfy, this could have influenced
the perceived degree o f fatigue experienced by the subjects.
Richardson and Ream (1997) conducted a stu<fy that reviewed self-care
strategies used by patients receiving chemotherapy. The results o f their research
revealed that subjects knew what to do to help their fatigue but only instituted
those measures on half o f the days that they experienced fotigue. The
recommendation offered by these researchers was the idea that if selficare
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measures were efTective in relieving fatigue partially, then the role o f the
oncology nurses who care for them should involve routine assessment o f cancerrelated fatigue. Longman et al. (1997) supports the findings o f Richardson and
Ream. Suggesting, nursing needs to clinically individualize nursing interventions
for each subject in order to impact the degree o f fatigue that results from
chemotherapy.
This stu<fy also did not evaluate if any o f the subjects exercised regularly
or participated in routine physical activity which may have influenced the degree
of fatigue experienced by subjects. According to an experimental stwfy conducted
by Mock et al. (1997) levels o f physical, functional, and symptom intensity were
compared in women receiving concomitant chemotherapy and radiation. Those
subjects involved in a walking program experienced less fatigue (p= .003) than
those who were less active, once again suggesting the idea that there may be more
to managing fatigue in subjects than providing education. Nurses may have a role
in prescribing and monitoring exercise and self-care activities that may reduce
chemotherapy side effects to facilitate adaptation to chemotherapy-induced
fatigue.
Relationship o f Findings to Conceptual Framework
The findings in this stutty demonstrate that assessment o f fatigue in
patients receiving chemotherapy is an important function for oncology nurses. All
the subjects in the study demonstrated an increase level of fatigue while receiving
chemotherapy. This finding supports that the fotigue level o f patients should be
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assessed by the on co lo ^ nurse and is important in providing quali^ care. Piper
(1997) suggests that fatigue is multidimensional and developed a specific tool
measuring fatigue to measure multiple concepts.
Piper’s goal is that the PFS wül be used in the development o f
interventions that may provide guidance for adaptation to chemotherapy-induced
fatigue or patient related fatigue experience. Nearly every person experiences
fatigue, patients with cancer and those having chemotherapy treatments encounter
a fatigue that is not dissipated by a good night sleep. Fatigue in relationship to
Piper’s conceptual framework, involves subjective and objective measurements.
In order to best understand the individual perception o f fatigue. Piper developed
the PFS.
The PFS provides a tool to measure and assess Atigue, as well as an
insight into how an individual feels fetigue is interfering with their life. Further
testing of the PFS with a particular group o f subjects that had one type o f cancer,
age specific, same gender, and/or all receiving the same chemotherapy protocal
would be useful and provide more consistent data.
Piper’s bitegrated Fatigue Model looks at the physical, behavioral,
sensory, affective, and cognitive subscales o f fatigue. Just as these evaluate the
different degrees o f fatigue, so do the interventions that will help the subjects
adapt to chemotherapy-induced fatigue. Piper (1997) states that as alterations in
activity and rest patterns play a significant role in the prevention, cause, and
alleviation of fatigue, as do uimecessaty sedentariness, prolonged bedrest, and
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immobili^. Therefore identifying what subjects are doing on a daily basis to deal
with fatigue can lend insight in controlling fatigue in this select population o f
oncology subjects.
Understanding the mechanisms o f fatigue in subjects can help the nurse
offer measures that are essential m assisting them to cope with this distressing
experience. Using this foamework, the nurse can begm to assess possible causes
o f fatigue in a specific subject and select an appropriate intervention. The
subscales may provide insight into an area where the subject may experience a
greater level o f fatigue. This may be beneficial to the nurse, as she may be able to
provide more specific fatigue management measures.
Reviewing Piper's subscales, the researcher gives credence to the idea that
nutritional assessment may be overlooked. In this high-risk population o f
individuals, nutritional assessment, referral, and support is fundamental to fatigue
management
According to Piper (1991), instruction regarding fatigue should be
inclusive of the types o f symptoms that may be experienced (mental/cognitive,
physical, emotional, and behavioral). As these symptoms occur, understanding
and being informed of other methods that have been proven to be effective in
managing fatigue have been found useful in controlling and alleviating fatigue.
Symptom-specific information may be useful in reducing the level of
fatigue experience by subjects receiving chemotherapy (Piper, 1991). Patient and
family centered teaching may enhance a sense o f control and mastery over the
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familiar and reduce anxiety. In summary, educating patients and their families
about fatigue symptoms unique to them may be best able to influence fatigue.
This study did not reveal any significant difference between the two
groups experience with the level of fatigue. The idea o f familiarizing patients and
families with methods that may assist them in adapting to fatigue may enhance a
sense of control, therefore providing a reduction o f fatigue.
Limited research has been conducted to suggest which interventions are
the most viable and effective m helping patients adapt to fatigue. Piper et al
(1989) states the use o f a single intervention strategy for the relief o f Atigue can
provide only partial relief. Health care professionals need to combine their efforts
toward fatigue management strategies. Such various professional include the
nurse, physical therapy, occupational therapy, and dietitians to name a few. Along
with the patient’s passive, common-sense methods, interventions can be tailored
made to help each patient adapt to chemotherapy-induced fatigue.
Limitations
Sample size is recognized as a significant limitation o f thisstudy. The
level of nursing participation fiom the offices involved in gathering data for the
study in retrospect is also a major factor. The study used a small (n=I6),
convenience sample, and findings can only be generalized to this sample.
Moreover, missing data, disparity in size o f the group is a concern. The small
sample size limits the ability o f the results to be generalized to an entire
population. Since all o f the sites that participated in the study were oncology
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offices, it is impossible to generalize these results to a specific group o f subjects.
The fact that patients were voluntary and had the option o f not participating may
be another factor in altering the results, as only those patients who had some
interest in the topic may have participated.
It may have been beneficial but not practical to have the same registered
nurse (researcher) to assist all subjects in the completion o f the fatigue
assessment forms and instruct on fiitigue management methods. The fact that five
different ofBces and different oncologists were involved in the research project
may have affected the collecting data process.
Lastly, a pharmaceutical company created the booklet that was given to
patients. This attempt to advertise their product to improve blood counts may
have turned some patients off from reviewing the information and caused a
degree o f frustration for some o f the subjects if th ^ felt they could not relate to
the information.
Recommendations
In evaluating the results o f this stucty, it is evident that fatigue is prevalent
in patients receiving chemotherapy. Although this study did not support the fact
that instruction on fatigue management lowered the level of fatigue in this group
of subjects, it is believed that instruction on fatigue is important and can lower the
level of fatigue. However finding an effective teaching tool may be crucial in
fatigue management
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Implications for Nursing
Practice. The prevalence o f fatigue in cancer patients is common as
supported by the results o f this stuify. A holistic approach in managing fatigue
including complimentary strategies should be considered to meet patients
demands, coping styles, and preferences. The findings o f this study point to the
need to continue to find ways to help patients deal with fatigue. Teaching patients
about the fatigue experience as it relates to them treatment is a combined effort o f
the health cate team. Several strategies in the intervention may be necessary to
alleviate or control fatigue related to chemotherapy.
Nurses need to be aware of the various groups within the chemotherapy
populatioiL Research has pointed to the fact that various groups require different
strategies based upon age, sex, and other fiictors. Fatigue » just one other
important facet that the patient must overcome in their day to day battle with
cancer and nurses need to be proactive in the war against it
Education. Nurse educators need to impress upon nursing students the
importance of understanding the power that fatigue can have on our patients. This
includes how patients cope mentally, physically, emotional, and spiritually with
the effects o f fatigue. This holistic assessment must be taught to nursing students
so that appropriate interventions can be implemented. Oncology nurses who deal
with oncology patients must be taught that timely follow-up and evaluations of
fatigue is essential to the care o f patients.
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Nurse educators should also emphasize the importance o f developing
good collaboration skills with other health care professionals, since this will be an
important part o f their practice. This portion o f health care may be instrumental in
helping patients adapt to fatigue. The involvement o f nutritionists, physical
therapist, and alternative medicine may be beneficial to patients. Alternative
medicine may include imagery, herbal medicine, touch therapy, and various
patient directed therapies.
Administration. Nursing and health care administration should also be
aware of the affect of fatigue. Allowing nurses to attend conferences and
workshops regarding quali^ o f life issues, such as fatigue, and methods to help
patients adapt to it may overall benefit future patients. Promoting relationships
and collaboration between other disciplines to magnify the attempt to manage
fatigue is another way that adnmustrators can be involved.
Arranging opportunities or events in which nurses can teach, present
health care topics or research on fatigue, and manage chemotherapy induced
toxicity can assist patients. Administrators also need to be on the cutting edge of
new opportunities fi)r patients and nurses.
Research Fatigue has become a leading topic for research studies but
evidence-based strategies continue to be prominent problem facing patients
receiving chemotherapy. A range of interventions with different groups of
patients need to be assessed for comparative value across the spectrum of cancer
diagnosis and treatments. Designing and evaluating global interventions that can
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be tailored to meet individual needs and preferences are needed. The relationship
between fatigue and depression and other psychological status call for further
research exploration.
Summary

For many patients, fatigue is a significant problem. What works for one
patient may not work for another. Finding out what works best takes time and
effort The nursing profession must continue to try to find the answer to the
question o f what nursing interventions help patients adapt to chemotherapyinduced fetigue. Although this study did not demonstrate that education affected
the fatigue level o f the intervention group, nurses must continue to study what
interventions will make a difference to the patients level of fatigue. Working in a
collaborative fashion with each and every patient can only be a benefit in the fight
against chemotherapy-induced fatigue.
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APPENDIX
A
Outline for Nursing Inservice
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APPENDIX A
Outline for Nursing Ihseivice
I. Introduction to research project
n. Criteria for patient eligibdi^
A- 18 years old or older
B Able to read English
C. Any type o f cancer, chemotherapy treatment, but not receiving concomitant
chemotherapy and radiation.
D. Newly diagnosed or recurrent patient’s with cancer that are undergoing their
first course of chemotherapy.
m. Patient consent and Demographic form
A. If patient agrees to enter the stucfy^ proceed with Fatigue Assessment Tool
B. If patient dose not wish to enter stutfy reassure them that this will not affect
their treatment
C. If patient dose not wish to enter the study but wants to receive the Fatigue
Assessment Tool, the RN can give that to them.
D. Instruct RN to read through the Fatigue Assessment Tool with the patient
IV. Familiarize RN with the logbook
A. The designated location will be secured and accessible only to the RN and the
researcher.
B. The logbook will include the patient’s name. Sex, age, telephone number, and
their assigned number that distinguish them from the control group and the
experimental group.

48

APPENDIX
B
Permission for Use o f Assessment Tool and Model
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APPENDIX B
APPENDIX B

To: Barbara Piper RN
University o f Nebraska, Medical Center
600 South 42 nd Street
Omaha, Nebraska
91598-5330

From: Karla Baker RN, MSNo
4258 13l“ Ave.
Hamilton, MI 49419
616-751-2169 (H)
Dear Barbara,
I am writing to ask permission to use your PFS as the mstrument in my masters thesis
proposal. I am also seeking your permission to use the Fatigue framework for the
conceptualization o f fatigue in my thesis. My source came from the following reference:
Piper, B.F., Lindsey, A. M.,& Dood, M. J, (1987). Fatigue mechanisms in cancer
patients: Developing nursing theory. Oncology Nursing Forum. 14. p. 19.
Piper, B.F., Ehbble, S i . , Dodd, M .J., Weiss, M.C., Slaughter, R_E., & Paul, S.M.,
(1998). The revised Piper &tigue scale; p^chom etric evaluation in women with breast
cancer. Oncology Nursing Forum. 25. ^ 77-684.
If permission is granted, please sign below and return to the above address. Thank you.

Sincerely
Karla Baker
^gnature

date
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To: Barbara Piper

^

x.,

c^A i , ^

a

^

Omaha, Nebraska
^598-5330
From: Karla Baker RN, MSNo
4258 131" Ave.
Hamilton, MI 49419
616-751-2169 (H)
Dear Barbara,
I wrote to you previously regarding the use o f your Integrated Fatigue Mmfel Theory
and Assessment tool. You approved this use, so now I am requesting permission to
include your actual Fatigue Integrated Model figure. I obtained it through the internet
from the Oncology Nursing Society, FIRE education material. I down loaded it into my
thesis. I will include the co p y ri^ t to 1995 Barbara F. Piper, DNBc, AOCN, FAAN.

Inîtegi^îed Fa%ue
JBMHHcstFactcrs |

'fcaKUaaoitfttlMiUtamr ]
B w s r SûbçM i n t t i r s .

-ChangHinf

%
♦ — 1 jiO A fyfR M tP aim i» 4

SiwcWjtePaBT»- I
OiwasB»altairs ~~l

i SyayiBB^Paewns
i

PUmr*

)

CopytiQMC 1MSSai&araP.P^.CNSe.RN.ACCM.R«AN

If permission is granted, pleas&sign below and return to the above address. Thank you.

Signantre

I date

Sincererly,
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Karla Baker RN
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APPENDIX c

Address
Dear Physician,
I am a registered nurse currently woildng towards a master’s degree in Nursing at Grand
Valley State University. I am exam ining how early nursing intervention effects fatigue in
patients receiving chemotherapy.
For the purpose o f this stwfy. A questionnaire is being presented to these patients regarding
their level o f fatigue. The patients will be asked to rank how they feel from a scale o f 0-10.
A copy o f the questionnaire is enclosed for you to see.
I am asking your help, in this project to determine how patients respond to fatigue if they
receive additional information regarding measure that they can utilize to help manage their
fatigue. The findings will help us provide improved care to our patients and a greater
knowledge of fatigue as it relates to chemotherapy.
Your oncology nurses will be determinmg if patients qualify for the study. They will then
provide standard chemotherapy information to a certain set of patients, and to the other set,
they will receive an information sheet and booklet on fotigue management A cover letter
will accompany the questionnaire and this will reinforce that this study is voluntary and
will not effect the care that th^r receive from your practice. A total goal o f 30 patients are
being selected for the stwfy. There are no risks involved in participation. The patient may
choose to end participation at any time. In order to assure that patient’s questionnaires
remain anonymous, they are asked to not put their names on it
If you have any questions regarding the study, you may contact myself, Karla Baker, at
(616) 751-2169. Members o f a supervisory committee at Grand Valley State Universify
have approved this study for the Protection o f Human Subjects, fr*you have any questions
regarcÉig the approval of this study, or subject’s rights, you may contact the chairperson of
that committee Paul Huizenga, at (616) 895-2472. Results o f this study will be available to
you on request.
Thank you for your wiliness in allowing your office to participate.

Sincerely
Karla Baker, BSN
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APPENDIX D

G r a n d 'SAlley
S x A T E U S m . 'E R s r r i '
I CA>t?üSDRJVS • ALL&NOAL£MICHICs,N49-WI-9-fC3 • 6 1 5 /3 9 5 -é ô H

April 7, 1999
Karla Baker
4258 UP'^Ave.
Hamilton, MI 49419
Dear Karla:

Your proposed project entitled Early Nursing Interventions and Their Effects on
Fatigue on Patients Receiving Chemotherapy” has been reviewed. It has been
approved as a study which is exempt from the regulations by section 46.101 of the
Federal Register 46(16^:8336. Januarv 26. 1981.
Sincerely,

Paul Huizenga, Chair
Human Research Review Committee
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APPENDIX E
Script o f Oncology Nurses
Mr. orNfrs._________,
Our office is helping a nursing student by the name o f Karla Baker,
conduct a study on what level o f fatigue you are currently experiencing today
again in 6 weeks from now. We have a fktigue assessment fr>rm that will take
about 10 minutes to fill o u t You can fill it out while you are waiting, or if you get
called into the exam room before you are finished, you can finish the assessment
form then, ffiat any tim e you foel like you don’t want to finish the assessment
form, you may stop. There won’t be any penalty to if you don’t finish. There is
also no risk to you in participating in the study. Karla does not want to know who
filled out the assessment form. By filling out the form you are giving your
permission to be included in the stwfy. When you are done, you can give me the
form or put in the envelope provided by Karla and we can mail it or you can mail
it yourself. If you have any questions about the study fell free to come and ask me
any questions or Karla has provided her name and telephone number and you can
call her yourself.
Please thank the patients on my behalf for being willing to participate.
Karla Baker
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APPENDIX F
Dear Participant,
Fatigue is one o f the most common side effects o f cancer
treatment Although little is known about the scientific basis for managing
fatigue, there are numerous measures that can help.
I am a graduate student in the nursing program at Grand Valley State
University. The study is titled ‘'Early nursing mterventions and their effect on
patient’s receiving chemotherapy”.
You are 1 o f 30 patients selected to be included in this sturty. You will be
asked to fill out two questionnaires. The first will be filled out today and will take
15 minutes. The questionnaire asks you to rank how you feel on a scale ofO - 10.
The second will be filled out at your home six weeks from now and will be sent
directly to the researcher. In order to make sure no one knows who filled out the
questionnaire, please do not put your name on i t The fact that you agree to fill
out the questionnaire indicates that you understand what this stucfy is about and
voluntarily agree to be in i t You may, however stop at any time if you foel you
cannot or do not want to continue with the fotigue questionnaire.
Risk associated with participation in this stwfy includes time loss and
additional stress by having to participate in a stwfy on your first day of
chemotherapy. Your participation in this study may benefit you and others
undergoing chemotherapy treatments through the improvement o f fatigue
management
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APPENDIX G
Directions: For each of the rollowing questions, circle the number that best describes the fatigue you are
experiencing now. Please make every effort to answer each question to the best of your ability. Thank you very much.
I. How long have you been feeling fatigued? (check one response only)
a. Minutes_____
b. Hours_____
c. Days_____
d. Weeks_____
e. Months_____
f. Oihet (please describe):.
2. To what degree is the fatigue you are feeling now causing you distress?
No distress
0
1
2
3
4
5
6
7
8

A great deal of distress
9
10

3. To what degree is the fatigue you are feeling now interfering with your ability to complete your work or school ac
tivities?
None
A greatdeal
0
1
2
3
4
5
6
7
8
9
10
4. To what degree is the fatigue you are feeling now interfering with your ability to visit or socialize with your fiiends?
None
A greatdeal
0
1
2
3
4
5
6
7
8
9
10
5. To what degree is the fatigue you are feeling now interfering with your abiliqr to engage in sexual activiQr?
None
A greatdeal
0
1
2
3
4
5
6
7
8
9
10
6. Overall bow much Is die fatigue, which you are experiencing now, interfering with your ability to engage In the Idnd

o f activities you enjoy doing?
None
0
1
2
3

4

5

. 6

7

8

A greatdeal
1 0 .

9

7. How would you describe the degree of intensity or severity of the fatigtie whidi you are experiencing now?
Mild
Severe
10
7
8
9
0
1
2
6
3
4
5
To what degree wou d you describe the fatigue which you are experiencing now as being:
Unpleasant
8.
Pleasant
8
9
10
2
3
4
5
6
7
. 0
9.
10.
11.
12.

Agreeable
0

2

3

4

5

6

7

8

9

Disagreeable
10

Protective
0

2

3

4

5

6

7

8

9

Destructive
10

Positive
0

2

3

a

5

6

7

8

9

Negative
10

Normal
0

2

3

5

6

7

8

9

Abnormal
10

13. To what degree are you now feeling:
Strong
0
1 2
3
4

5

6

7

8

9

Weak
10

14. To what degree are you now feeling:
Awake
0
1 2
3
4

5

6

7

8

9

Sleepy
10

15. To what degree are you now feeling:
Lively
0
1 2
3
4

<

6

7

3

9

Listless
10
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16. To what degree are you now feeling;
Refreshed
0
1 2
3
4

5

6

7

8

9

Tired
10

17. To what degree are you now feeling:
Energetic
0
1 2
3
4

5

6

7

8

9

Unenergetfc
10

IS. To what degree ace you now feeling:
Patient
0
1
2
3
4

5

6

7

8

9

Impatient
10

19. To what degree are you now feeling:
Relaxed
0
1
2
3
4

5

6

7

8

9

Tense
10

20. To what degree are you now feeling:
Exhilarated
0
1
2
3
4

5

6

8

9

Depressed
10

21. To what degree are you now feeling:
Able to concentrate
0
1
2
3
4

5

6

7

8

Unable to concentrate
9
10

22. To what degree are you now feeling:
Able to remember
0
1
2
3
4

5

6

7

8

Unable to remember
9
10

23. To wbat degree are you now feeling:
Able to think deaHy
0
1
2
3
4

S'

6

7

8

Unable to think dearty
9
10

24. OveralL what do vou believe is most directly contributing to or censing your feti^ue? _
25. Overall, tfie best thing you have fooad to relieve yoor£uigDets;_
26. Is there anything else you wooldlSce to add that would describe your &tigue better to os?.
27. Are you experiencing any other symptoms tight now?
No
Yes Please describe.

*01984, Barbara F. Piper; revised 7/1Q/97; reproduced with permission.
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This

su rv e y

is divided inco

2

seccioos. The first is the infbrroacioa section that asic

you some basic questions about yourself, your diagnosis, and your treatm ent. The seconc
section is the rnain part o f this sur'/ey. Please follow the directions provided and answer
a llo f the questions to the best o f your ability. Thank you for y o u r time.
SECTION I—Information
I. Age: _____________________

2.Sex:

M

3. T>-pe o f cancer:_____________________________________________________________
4. Chemotherapy regimen (nam e o f chemotherapy drugs you are receiving):___________
_(if you are unsure, please ask a nurse to fill in this information for you
5. Previous histcr.* o f cancer? Y es _____ Ko
If yes, w ere you treated w ith (circle ail that apply):
a. chem otherapy b. radiation c. surgery
6. V,"here do you live? in a house

in an apartment

in a nursing home_

other (please specify)^
7. How many people live w ith you? __________

(please include all adults and children'

3. O f those living with you. how many can you rely on for some type o f sup con?_______.
(for example, help you w ith housekeeping, meals, errands, etc.;
9. Do you have any type o f hom e care? Meals on wheels
Ho so ice

Nursing serdces_

Ox’/aen_____ O th er____________________________________

10. Do you have anv other medical condition? [f so. please specify
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APPENDIX H

Fatigue Education
Specific Suggestions
S it or lie down often: short periods o f rest are better
than long ones. This is because the heart rate slow s down
very quickly a t the beginning o f a rest period, but more
slow ly at th e end o f the rest period. M ary short rests, then,
give the heart more chances to beat slower and then tire
less.

Take naps: Naps can be helpful as long as they don’t
keep you firom falling asleep a t night.
Plan activities: lim it the energy used on planning
activities. Do the im portant activities first, and decrease
the num ber o f less important activities. M ost people have
energy for the things that th ^ enjoy and feel best doing.
Let others help you by telling them w hat they can do for
you. Try to keep your daily life sim ple.
Read: m any people find that reading helps them to keep
their m ind oflTtheir fatigue.

66

W alk/exercise: regular. light exercise such a s walking has
been show n to decrease fatigue, as w ell as nausea and
vom iting.

f
U se distraction: People u se many routines to keep their
m inds off o f how tired th ^ are. This m ight include: going
to woric. taking car rides, listening to soft m usic or
relaxation tapes, doing yoga, or anything else that helps
you to relax after a hard Day.

Sleep: Start or follow a normal sleeping routine.

E at a balanced diet: eating the right foods help give
you energy. The National Cancer Institute publishes a free
booklet called "Eating Hints".
Make su re VOU a"^ fom iortable: When you are too cold or
too hot th is may m ake you tire more quickly. Avoid
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tem perature greater th a n 75T and h u m id i^ greater than
60%.
M aintain you social life: To lessen fatigue, m any people
lim it their social life an d fu n activities first. Try to balance
between the activities you m u st do and those th a t m ake
you happy in your daily life.

Taken from: SkaNa, K., and Laçasse, C., (1992), Patient Education
for Fatigue, Oncoloqi Nursna Fomm.19 p 1537-1541.
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Physician
Phone number
Emergency number
Nurse
Phone number
Pharmacist
Phone number
Social worker
Phone number
Dietitian
Phone number

Fatigue. The Better You
Untlerstaiid It, the Better
Vou Can Manage It
Must caucui luiliuitis nut
only havu to cope with tlieif
(lisoasc bill with uthur syinpionis
US wuH. such us luiiisuu. vuiniiiny,
tiredness, or (aligne. Fatigue is ultcn a
side effect of many cancer treatments.
Sometimes, just cfianging your routine causes you to feel tired,
weary, wiped out. weafc. and fatigued. Changes in your sleep, daily
activity, or eating patterns also can cause fatigue, as can anxiety,
depression, stress, and anemia fa decrease in llie iiumher of your
rod blood colls).
Tltis Imnldnt is designed In help you lietler understand your
fatiguo and to let you know that there ate heallficaie professionals
who understand what you are going through. It includes helpful
hints on how to manage your fatigue so that you can help yourself
feci hotter and make your life easier, This booklet also includes a
section that answers some of the more common rpiestions that
most cancer patients have about fatigue. Hopefully, you will learn
ahoiit Irealmonis and ways of coping willi faligiio liial can enahle
you to perform the activities you want and need to do.

ynii (oui tuoto tired than usual or tiro more (luickly
after ceinpletiny usual acjtivilics. It may also occur
when you are not doing anything.
Fatiguo can he more than just a
fooling o( being constantly tired.
Listen to music, watch youmay also experience dilliculty
television, or read rather performing everyday activities
than focusing on your

housework, showering.
and cooking. Dilliculty in walking,
disease, symptoms, or
talkiiig. concentrating, and making
how you feel.
decisions may all Ire symptoms ol
fatigue. Sometimes, you just do
not feel like yourself. Often, it is
difficult trying to deal with family members or other
people who may he frying In help you.

Emotional stress, coping with anxiety,
conflict, sadness, even tcnsiorr arnorrg
loved ones, require extra energy
and cart cause fatigue.
Changes in your daily routine
also contribute to fatigue. As
a result of your cancer treatment, your
sleeping, eating, and working patterns
maycltange.
The fact is. your entire life is being turned
upside down and yet so much is still expected of you. Yoir .still Itavc
to travel to and from treatments. You still have to function. Yotr still
have to cope. You have to coll rtpott yoirr body to do so much more
than it may want to do or be able to do.
Another common cause of fatigue associated with cancer is
cliemnlherapy. lire treatmrrnt itselt is a factor, atong with It.s sitir;
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oKocts. Pütionts who oxporionco nausea or vonutiiuj
may not cat cnoiKjh to keep up tlicir energy levels.
Another common side effect of cancer treatment is
anemia. Anemia is also known to cause fatigue.

Suggestions To Help You
Control Fatigue
It Is important to become
more selective in the
type of activities you

Here are some things you can do
to help you fight and manage
fatigue instead of giving in to it.

choose to pursue, wlieu,

Ileassess your goals. Examine your
and for how long
goals, both long* and short-term.
you do them.
Reassess those goals to make
them realistic and reachable. Also,
be selective in what you choose to
accomplish: this will help you to lessen any leetings
ol guilt, stress, and anxiety— and the fatigue that
accompanies these emotional feelings— when you
cannot achieve certain goals.
Make iin iii.iivilies list. Actually, make two. On
the first one, list all of the activities you must
/«.'//rwrn llial day fin ihe second, list llieseaclivilies

that you sliouMficflonnM that can wait until some uitrei time. Du
this on a daily basis, only attending to activities from your should
perfonu list when you feel like doing them.
Keep an activities iniiiiial. Write down what you do dining the
day and note your energy and fatigue levels. Alter a lew days,
review your entries to see if you can identify any patterns For
example, what has caused you to feel more exhausted? What h.ive
you been doing prior to the times when you have felt your best? fiy
to minimize those activities that arc the most tiring and keep doing
the ones that make you feel good. Work on your most challenging
activities during the time of day you feel you have the most energy.
I.eain In itacoyoursell.Try
to find a comfortable pace for
performing the activities you
want to pursue. Don't overdo
it, as it is easier to accomplish
the activities you want to
accomplish if you avoid doing
too much too soon.

Adhere to au exercise
program. Ask your
healthcare provider
to design a
program for you.

Gel plenty ol rest, bill don'l overdo il. If you arc like most
people, you associate feelings of fatigue will) the need for more
lesl. I liiwevei, sliidies show Ilial loo much lesl can cause a drop in

l i — . • / I,.
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your hüily‘s ability to produce energy. In other words,
the niiiin ymi rest, the more tired you leel. One thing
you might try to do when you (eel fatigued is to
spend less time lying down and more time sitting or
standing, even walking or performing other activities
whenever possible. Many people
Several short rest
find that light exercise, such as
periods may be more
walking, actually decreases their
fatigue. Consult with your health*
beneficial than one
care provider about the host form
long rest period.
and type of exercise for you.
Chnil peiiods of rest are host. When you need
test, sit nr lie down more often, hut only for sirort
periods of time ratirer than long periods of time.
Your heart rate slows down more r|uickly at the start
of a rest period and more slowly as you continue to
test. Ihns, several shtrri rrrsts give yoitr freart mort;
opportunities to beat slower and to help you to
conserve your energy.
If you ward lo riaji, take aller a t:al. Cat naps are
short naps that may well help you conserve your
energy, (jut ho cautious; don't nap so much that it

interferes with falling asleep at night. A full night's sleep, or an
uninterrupted slerrp from which you awaken feeling refreshed, is
also im|)ortant and helps yon to conserve energy
Diiii'l he ahairl in a:,k liti .c.M .i.ince The fact is, if you plan
your activities, you arc going to have more energy for pursuing the
activities you enjoy and feel best rioing. What about everything
el.se? Ask for assistance with such tasks as housekee|)ing. laundry,
shopping, and carpnoling. I tientls and family should he happy lo
help you, and it makes them feel good knowing that they are rioing
sornolfiing to help or please you. If you do not feel like sncialifing
wlicn people arc assisting you, simply tell thorn you do not feel like
talking. Tliey will understand.
Keep your iiiinrl htrsy

Delegate specific

Tliink about tilings otirer than
activities and
your fatigue, illness, or treat- responsibilities to others

fl"

in order lo conserve

go to a rnovit!, or meet
friends. Many people have
your energy.
found that reading, relaxirtg,
or listening to music is helpful in managing their fatigue. lire
important thing is lo keep your ritind busy.

DIMENStONS

I,Il wi'ii iiiiil (Ilink lilniily. Maintain a wcllbalancod dioi with plenty of fluids. Ealing grains,
green vegetables, legumes (tieans), and foods high
in iron (spinach and kale) can help you maintain your
energy level, as can eating more frequent, smaller
meals or snacks throughout the day. Consult with
your healthcare provider aliout the best diet (or you.
talk In yiHit ductni. If you are fatigued, talk to
your doctor.

Anemia may ho the cause of your fatigue.
Anemia can be treated. Dtood transfusions are used
to treat severe anemia, but may cause allergic
reactions, levers, chills, infections, and headaches.
In addition, blood transfusions may l)B inconvenient,
costly, and time consuming.
Another way to.treat anemia due to chemo
therapy is with Epoetin alia (recoinhinanl human
eiytlnopoieiin). Epoetin alfa increases the numhcr ol
red blood cells in your body.
How (lorn; il work? Epoetin alfa is a hormone
produced hy ONA technology that is identical to the
natural erythropoietin produced by your body.

Eiythropoiotin stimulalo!: yoiii buiiu iiianow lu inoducu led triuud
cells. Red blood cells carry oxygen lioin your lungs throughout your
body. The oxygen is necessary to convert calories burn the foods
you eat into energy. The fewer the number of red blood cells, the
less oxygen gets to your body, and the less energy you will have.
Consequently, you feel more tired or fatigued.
Your body may not produce enourjb erythropoietin when you
have cancer or are receiving cancer treatment, particularly
chemotherapy. Therefore, your body may not produce enough
rod blood cells. As a result, anemia occurs. Epoetin alfa can
stimulate your bone marrow to inraease its prrrduciion of red
blood cells, just like your natural erythropoietin, Epoetin alfa
is administered by an injection under the skin and takes about 4 to
8 weeks to increase the number of red Irfood
ccffs in your body and correct your anemia.
Epoetin alfa may cause allergic
reactions, an increase in heart rate,
and an increase or decrease in
blood pressure. Epoetin alfa
may not work for èverybody,
Ask your doctor if it would be
suitable treatment to help your anemia.
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How Linda Copes
Four yours ago, Linda wont to Iter doctor for a
routine visit. After her examination, her doctor said
that he wanted to. perform additional tests, and
Linda and her husband immediately agreed. Their
worst fears were realized when they found out she
had cancer. Her prognosis w as not promising; her
disease was considered extensive and doctors gave
Linda just I year to live.
It's been a long haul for Linda. Before receiving
chemotherapy, she w as a "fireball," one of those
people who seemed to have "boundless energy."
But along with chemotherapy came fatigue.
Linda's fatigue became so intense that she no
longer fell she w as the same person.
Her husband, though supportive, w as (juiet
and reluctant to share his feelings. Her son saw her
simply as someone who was always sick.
Consequently, Linda had a lot of stress in her life.
She couldn't sleep through the night. Fatigue had a
negative impact on her self-esteem and her self

image. She had some geud days, hut they did mil tunie e a s d y slic had to constantly work at them.
Yet the more Linda worked to overcome the fatigue, the mure
fatitjtie she had to deal with, as a result of the cumulaitvc side
effect of her chemotherapy.
Eventually, Linda could no longer cope with her fatrgtre and
asked her doctor if there was anything ho coirld do to Ittdp her. Her
doctor prescrilMid Pnf)CH IT“ (Fprrelin alia). Il Irrtrk a imv wrreks. hiti
soon Linda started to feel a little more like her "old self ."

How Woody Copes
At 34 years of age, Wootly consitlcrod himself pretly successful
He worked hard and was looking forward to buying a house in the
near future.
But a short time ago. Woody noticed he did not feel well It
w as nothing that happened overnight. He first noticed a loss ol
energy, and tlicn a gradual loss of strength. On Iris lit si vrsit to hrs
doctor, he was found to ho very anemic and fatigued.
This initial visit led to more visits and nurrrerous lesis and.
within a few weeks, Woody was diagnosed v/ith acquired
immunodeficiency syndrome (AIDS)-related lyrirplrortra.
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Tlio ni)ws siîomwi lo linfnol Wooily. Ho hooomo
ovoii 100(0 (ati(jiiod. (irouchy. aiul moody. Before
looij, Woody could do very littie lor himself and
needed help to go everywhere, even to the
bathroom.
Because Woody and ills oncologist have an open
relationship, his doctor has been very helpful. He has
made Woody feel like a person, not just a patient.
His docioi. like many others, feels this level of
patient involvement and interest is important in
caring for people dealing with cancer.
Because anemia and fatigue have plagued
Woody since his first visit, his doctor prescribed
Epoetin alia. He receives injections of Epoetin alfa
three times a week. Woody now feels loss tired and
has more determination to pursue the goals ho
wants to achieve.
Woody views Epoetin alia as his second chance
to perform the activities he wants to perform while
he still is physically able. Woody understands
that most activities he w ants to accomplish will
still be citallenging. but he w ants to take on those

challenges. Woody is deleioiioed lo lake lliiogs as lliey cuoie .nut n,
live his life as fully as jtossihlo.

Answers to Commonly Asked Questions About

Fatigue
/Ve always beon a privalo pnisnn. but Ivn mrnnily luum

il'mjimotl with cancer. Do you think a supiiotl gioup would be belplul
forma?
Many patients with cancel

a.Hl Ihoir cWvo's IW
groups to lie very comforting. They
gain answers to many gueslions
and sup|)ort for what they're going
through. Ask your healthcare
professional how to contact a
support group in your area.
Are Ibero foods I should oal
lo maintain my energy level?

Eat a balanced,
complete
diet that provides
plenty of complex
carbohydrates
leg, grains, legumes,
vegetables) to give
your body
constant energy.

A diet high in protein,
vitamins, and iron is necessary lo provide Ihe milrieois needed lo
produce rod blood cells. Ask your doclor about your rliut anil wbeibcr
you should be taking vitamin supplomoois.
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I've alwiiys been an aviti reader, rarely wilhout
a Im k in my bands during my free time. Lately, lean
hardly read a page.... tcanUeem to concentrate on
anything. Is this related to fatiguo?
Thn ii)üi)ility to conccDlralo is n common
symptom of Intiyuo. Many fatigued |)ationts liovo
traul)ln conccntratiiuj wlion reading, talldng, or oven
walcliiny a favorite TV strow.
I'm in a support group, and most
Maintain a daily/weekly others in tire group can identify
journal lo identify

my constant feeling of fatigue.

changes in energy levels

overcome my fatigue, but they
and factors that increase
^
a n ,m lOf

decrease fatigue,

they feel better vdien I don't?

Tliere are no standardized medical
treatments for fatigue. Wlrat worlcs for one person
may not worl< for another. Finding out what works
and wiiat doesn't work for you may take some time.
Talk to your hcaltlicare provider.

Since being diagnosed with imiuit, I feel mam timd v. itli eveiy
passing day. Yet. (don't want to bother my doctoi with sonmibing
so insignificant. Whom else should I ask about this ?
First of all, fatigue is not insignificant. Wlien sometliiiig has such
a negative effect on your life, it's important and significant. Ask
your doctor about your fatigue, lie or she can deteimine what is
causing your fatigue and can suggest treatments to help you (eel less
tired, tl your fatigue is caused hy anemia, there may he treatment
options available to help you overcome yeur fatigue. One option is
Epoetin alfa, wftilo another option is the administration of a red triood
coll transfusion. However, as with any metlical contlitiun, not every
(rationl's fatigue will rcsponil to Ihese lreatmr*nts. Soineiimes fatigue
is caused by other factors that may retjuiic different medical care
Your doctor can discuss the henefits and limitations associated with
each treatment.

Treatments That May Help You Feel Better
Fatigue can Ire one of the most depressing, destructive, anil
distressing complications associated with cancer and chemo
therapy. Although there are no slandaidizeil medical treatments 1er
combating fatigue, there are ways to cope with it. Patients who
have anemia, and (Ire assor.ialetl fatigue, may often benefit finni
medical treatment.
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Talk to Your Healthcare Provider
Coinitiuniculo immediately with your healthcare
provider if your fatigue becomes:
• Unusually severe or not consistent with the
type of activity undertaken
• Disiuptivo to social activities or activities of
daily living
• Unrnlinvndhy rest nr sleep
• Constant or recurrent

Ask Your Healthcare Provider for
Additional Information

4

If you would like additional information about
fatigue nr anemia, ask your doctor or nurse. Ho or
she can provide you with the information you need.
In addition, your doctor or nurse can put you in touch
with local support groups and provide you with
suggestions for other booklets that may bo helpful to
you in dealing with your illness and treatment. It is
important lo keep all scheduled medical appoint
ments. If you arc unable to attend an appointment,
contact your healthcare provider immediately.
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